Tae-Kyung Yoo

Asan Medical Center

H指数:0

被引数:1

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chemoendocrine therapy versus tamoxifen with ovarian function suppression in women with node-positive breast cancer

化疗内分泌治疗与抑制卵巢功能的他莫昔芬在淋巴结阳性乳腺癌患者中的比较

Breast Cancer Research and Treatment

IF3

2026-11-090

PRE

ASO Visual Abstract: Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast Cancer

ASO视觉摘要：在未筛选的ER低表达/HER2阴性乳腺癌中胚系BRCA1/2突变的患病率

Annals of Surgical Oncology

IF3.5

2026-07-230

PRE

ASO Visual Abstract: Omitting Axillary Surgery for Patients with Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery

ASO视觉摘要：对保乳术后同侧乳腺肿瘤复发患者省略腋窝手术

Annals of Surgical Oncology

IF3.5

2026-03-300

PRE

Pregnancy after breast cancer treatment in young patients

年轻患者乳腺癌治疗后妊娠

Frontiers in Oncology

IF3.3

2025-08-250

Prognostic value of residual cancer burden after neoadjuvant chemotherapy in breast cancer: a comprehensive subtype-specific analysis

新辅助化疗后残留癌负荷在乳腺癌中的预后价值：一项全面的亚型特异性分析

SCIENTIFIC REPORTS

IF3.9

2025-04-220

Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases

曲拉留珠单抗 govitecan 在中枢神经系统转移的乳腺癌患者中的真实世界结局

NPJ BREAST CANCER

IF7.6

2025-03-051

Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence

循环肿瘤DNA纵向动力学在乳腺癌复发患者治疗监测中的应用

SCIENTIFIC REPORTS

IF3.9

2024-08-311

OAAI

The relationship between margin status of <2mm and local recurrence in DCIS patients

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Pregnancy Trends Following Breast Cancer Treatment: Insights from a Large Single-Center Experience

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Interaction of Prior Chemotherapy and Addition of Ovarian Function Suppression on Menopausal Symptoms in Tamoxifen-Treated Breast Cancer Patient: A prospective, Observational study

CANCER RESEARCH

IF16.6

2024-05-020

PRE

A retrospective cohort study on the effect of adding adjuvant ovarian function suppression to endocrine therapy in premenopausal women with T1T2 tumor hormone-positive breast cancer on survival and disease recurrence

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Diagnostic yield of contrast-enhanced abdominal staging CT in patients with initially diagnosed breast cancer

EUROPEAN JOURNAL OF RADIOLOGY

IF3.3

2024-02-010

PRE

Improved survival with ovarian function suppression in premenopausal hormone receptor-positive breast cancer: a propensity score matching of ASTRRA-trial participants with single-center postmenopausal patients

CANCER RESEARCH

IF16.6

2023-03-010

PRE

Long Term Outcome in Patients with Nodal-Positive Breast Cancer Treated with Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy

CANCER RESEARCH

IF16.6

2023-03-010

PRE

Chemotherapy is not mandatory in premenopausal, node-positive, HR+HER2-breast cancer patients

CANCER RESEARCH

IF16.6

2023-03-010

PRE

Diagnostic accuracy of a three-protein signature in women with suspicious breast lesions: a multicenter prospective trial

BREAST CANCER RESEARCH

IF5.6

2023-02-142

OAAI

PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection

SCIENTIFIC REPORTS

IF3.9

2021-10-019

OAAI

Cardiovascular events and mortality in a population-based cohort initially diagnosed with ductal carcinoma in situ

BMC CANCER

IF3.4

2021-06-263

OAAI

High Nuclear Expression of Yes-Associated Protein 1 Correlates With Metastasis in Patients With Breast Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2021-02-2514

OAAI

Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis

对于活检证实为腋窝淋巴结转移的乳腺癌患者，腋窝淋巴结清扫不是强制性的

BREAST CANCER RESEARCH AND TREATMENT

IF3

2020-04-2318

PREAI

Tae-Kyung Yoo

个人简介

教育背景

工作经历

荣誉奖项

研究方向